Literature DB >> 14757529

Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains.

Yukio Kawahara1, Kyoko Ito, Hui Sun, Masayuki Ito, Ichiro Kanazawa, Shin Kwak.   

Abstract

In human brain, developmental up-regulation in RNA editing at the Q/R site was evident in GluR5 and GluR6, but GluR2 editing in the white matter was down-regulated. Each ADAR mRNA expression was up-regulated in the gray matter, whereas differently regulated in the white matter. ADAR2 mRNA was not overexpressed in the brains of Down's syndrome subjects, nor was there any evidence of changes in the RNA editing efficiency of their GluRs.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14757529     DOI： 10.1016/j.devbrainres.2003.11.008

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN： 0165-3806


  19 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

2.  Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia.

Authors:  Baoman Li; Lu Dong; Bing Wang; Liping Cai; Ning Jiang; Liang Peng
Journal:  Neurochem Res       Date:  2012-06-19       Impact factor: 3.996

3.  Editing of the serotonin 2C receptor pre-mRNA: Effects of the Morris Water Maze.

Authors:  Yunzhi Du; Melissa Stasko; Alberto C Costa; Muriel T Davisson; Katheleen J Gardiner
Journal:  Gene       Date:  2007-01-12       Impact factor: 3.688

4.  Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes.

Authors:  Baoman Li; Shiquen Zhang; Hongyan Zhang; Leif Hertz; Liang Peng
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

Review 5.  Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.

Authors:  Shin Kwak; Yukio Kawahara
Journal:  J Mol Med (Berl)       Date:  2004-12-29       Impact factor: 4.599

6.  Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.

Authors:  Sivan Osenberg; Nurit Paz Yaacov; Michal Safran; Sharon Moshkovitz; Ronit Shtrichman; Ofra Sherf; Jasmine Jacob-Hirsch; Gilmor Keshet; Ninette Amariglio; Joseph Itskovitz-Eldor; Gideon Rechavi
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

7.  Spatio-temporal regulation of ADAR editing during development in porcine neural tissues.

Authors:  Morten T Venø; Jesper B Bramsen; Christian Bendixen; Frank Panitz; Ida Elisabeth Holm; Marie Öhman; Jørgen Kjems
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

8.  The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain.

Authors:  Amanda Wright; Bryce Vissel
Journal:  Front Mol Neurosci       Date:  2012-04-11       Impact factor: 5.639

9.  Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons.

Authors:  Takuto Hideyama; Sayaka Teramoto; Kosuke Hachiga; Takenari Yamashita; Shin Kwak
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Altered A-to-I RNA editing in human embryogenesis.

Authors:  Ronit Shtrichman; Igal Germanguz; Rachel Mandel; Anna Ziskind; Irit Nahor; Michal Safran; Sivan Osenberg; Ofra Sherf; Gideon Rechavi; Joseph Itskovitz-Eldor
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.